TCTP contains a BH3-like domain, which instead of inhibiting, activates Bcl-xL.

Abstract : Translationally Controlled Tumor Protein (TCTP) is anti-apoptotic, key in development and cancer, however without the typical Bcl2 family members' structure. Here we report that TCTP contains a BH3-like domain and forms heterocomplexes with Bcl-xL. The crystal structure of a Bcl-xL deletion variant-TCTP11-31 complex reveals that TCTP refolds in a helical conformation upon binding the BH3-groove of Bcl-xL, although lacking the h1-subregion interaction. Experiments using in vitro-vivo reconstituted systems and TCTP(+/-) mice indicate that TCTP activates the anti-apoptotic function of Bcl-xL, in contrast to all other BH3-proteins. Replacing the non-conserved h1 of TCTP by that of Bax drastically increases the affinity of this hybrid for Bcl-xL, modifying its biological properties. This work reveals a novel class of BH3-proteins potentiating the anti-apoptotic function of Bcl-xL.
Type de document :
Article dans une revue
Scientific Reports, Nature Publishing Group, 2015, 6, pp.19725. 〈10.1038/srep19725〉
Liste complète des métadonnées

Littérature citée [58 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01334033
Contributeur : Elizabeth Bernardo <>
Soumis le : lundi 20 juin 2016 - 12:33:13
Dernière modification le : jeudi 20 septembre 2018 - 17:02:01

Fichier

2016-thebaut-TCTP.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Citation

Stéphanie Thébault, Morgane Agez, Xiaoke Chi, Johann Stojko, Vincent Cura, et al.. TCTP contains a BH3-like domain, which instead of inhibiting, activates Bcl-xL.. Scientific Reports, Nature Publishing Group, 2015, 6, pp.19725. 〈10.1038/srep19725〉. 〈inserm-01334033〉

Partager

Métriques

Consultations de la notice

760

Téléchargements de fichiers

272